1. Home
  2. Labeler Index
  3. Advanced Rx Pharmacy Of Tennessee, Llc
  4. 80425-0116
  5. Product Images: Pregabalin

Product Images Pregabalin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 14 images provide visual information about the product associated with Pregabalin NDC 80425-0116 by Advanced Rx Pharmacy Of Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Fig 1

Fig 1

The text describes a table or graph showing the percentage of patients who improved after taking different medications. The medications listed are Pregabain at 200mg three times a day, Eresteln at 100mg three times a day, Pregatain at 25mg three times a day, and a placebo. The table also shows the percentage improvement in pain from the baseline. However, the format of the text is not clear, therefore, it might be difficult to accurately interpret the data.*

Fig 10

Fig 10

This appears to be a graph or chart with the percentages of subjects without LTR (unclear what LTR stands for) for a placebo group and a group taking pregabain, plotted against days from 20 to 180 in increments of 20.*

Fig 11

Fig 11

This is a statistical table showing the percentage of subjects improved from baseline to week 12 BOCF on pregabalin and placebo. The table shows a range of percentages from 70% to 100%. There are also numerical values on the X-axis ranging from 0 to 290.*

Fig 12

Fig 12

Fig 2

Fig 2

This is a table showing the percentage of patients improved after taking Pregabalin 106 mg three times a day. The table also shows the percentage improvement in pain from baseline. The text seems to be incomplete and contains some errors.*

Fig 3

Fig 3

The text indicates the results of a study where different doses of Pregabalin and a placebo were given to patients. However, the results are not clearly presented and the table seems incomplete. Therefore, a useful description cannot be generated.*

Fig 4

Fig 4

This is a chart that displays the percentage of patients who improved their pain levels from the baseline after taking either pregabalin at 200mg three times a day, pregabalin at 100mg three times a day, or a placebo. The numbers in the chart are difficult to read as an was performed on the text, resulting in some inaccuracies.*

Fig 5

Fig 5

Fig 6

Fig 6

Fig 7

Fig 7

Not available.*

Fig 8

Fig 8

The text shows the Responder Rate (%) for a clinical trial which tested doses of 2.5 mg/kg/day and 10 mg/kg/day compared to a placebo. The Responder Rates were 40.6%, 29.1%, and 22.6% for the different doses, respectively. The number of participants in the study were 93, 103, and 96.*

Fig 9

Fig 9

This appears to be a chart displaying the percentage of patient improvement in pain from baseline for different doses of Pregabalin and a placebo group. The highest improvement is seen with the daily dose of 600mg of Pregabalin. However, the chart appears incomplete and difficult to comprehend without additional context.*

Pregabalin 75mg Cap Qty 60 NDC 80425 0116

Pregabalin 75mg Cap Qty 60 NDC 80425 0116

Structure

Structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.